FDA Disclaimer

Important Note Regarding FDA Redulations

These statements have not been evaluated by the Food and Drug Administration.

Pranan EMF Protection Devices have not been evaluated by the United States Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease, disorder, or medical condition.

Product Classification

Pranan EMF Protection Devices are marketed and sold as consumer electronic products, not as medical devices. These products:

  • Are not subject to FDA approval or clearance processes required for medical devices
  • Have not undergone FDA review for safety or effectiveness
  • Do not require a prescription or recommendation from a healthcare provider
  • Are not designed or intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease

Claims Clarification

Any claims made regarding Pranan EMF Protection Devices are limited to their intended function as consumer electronics designed to interact with environmental electromagnetic fields. Any references to:

  • Reduction in electromagnetic field exposure
  • Effects on cellular function or biological processes
  • Support for individuals with electromagnetic sensitivity concerns

Are not intended to suggest medical benefits and have not been evaluated by the FDA for accuracy or scientific validity.

Non-Medical Product

Consumers should understand that:

  • Pranan EMF Protection Devices are not medical equipment
  • These products have not been clinically tested according to FDA standards
  • The FDA has not reviewed or approved any claims regarding the effectiveness of these devices
  • No claims are made regarding the ability of these products to prevent, treat, or cure any health condition

Electromagnetic Hypersensitivity Advisory

Electromagnetic hypersensitivity (EHS) is not currently recognized as a medical diagnosis by major medical organizations in the United States. The FDA has not validated any devices for the diagnosis, treatment, or prevention of symptoms attributed to EHS.

Health Recommendations

If you experience health symptoms you believe may be related to electromagnetic field exposure:

  • Consult with a qualified healthcare provider for proper medical evaluation
  • Do not use our products as a substitute for professional medical care
  • Do not discontinue any prescribed medical treatments without consulting your healthcare provider
  • Seek appropriate medical diagnosis for any persistent or concerning symptoms

Individual Variations

The perceived effectiveness of Pranan EMF Protection Devices may vary between individuals. We cannot guarantee specific outcomes or improvements in any symptoms potentially associated with electromagnetic field exposure.

Consumer Safety

While our products are designed with consumer safety in mind:

  • They have not undergone FDA safety evaluation required for medical devices
  • Individuals with implanted medical devices (pacemakers, defibrillators, etc.) should consult with their healthcare provider before use
  • Those with pre-existing health conditions should discuss use with qualified healthcare professionals

Legal Compliance Statement

This disclaimer is provided in compliance with FDA regulations and Federal Trade Commission guidelines regarding advertising and promotional claims for consumer products. All marketing materials and product descriptions are designed to avoid making unsubstantiated health claims.

Reporting Concerns

If you experience any adverse effects while using our products:

  • Discontinue use immediately
  • Consult with a healthcare professional
  • Report your experience to Pranan Technologies customer service
  • Consider reporting to the FDA’s MedWatch adverse event reporting program if appropriate

By purchasing and using Pranan EMF Protection Devices, you acknowledge that you have read, understood, and agree to the terms of this disclaimer.

This information is provided for educational purposes only and is not intended to replace professional medical advice.

Last Updated: April 4, 2025